Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolismJean‐Charles Lambert, Florie Demiautte, Fanny Eysert et al.|Acta Neuropathologica|2016Cited by 78